GeneralProduct News

Pirfenidone Clonmel

Clonmel Healthcare is delighted to announce the launch of Pirfenidone Clonmel 267mg and 801mg film-coated tablets.

Pirfenidone Clonmel is indicated in adults for the treatment of mild to moderate idiopathic pulmonary fibrosis (IPF).

Full prescribing information is available on request or alternatively please go to  Medicinal product subject to medical prescription.

Please contact Clonmel Healthcare on 01-6204000 if you require any additional information.

PA 126/350/1-2. PA Holder: Clonmel Healthcare Ltd., Clonmel, Co. Tipperary. Date prepared: November 2022. 2022/ADV/PIR/287H.


Pirfenidone Clonmel

Leave a Reply

Your email address will not be published. Required fields are marked *

Please Confirm

This website is only for the eyes of medical professionals. Are you a medical professional?